GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » AstraZeneca Pharma India Ltd (BOM:506820) » Definitions » Price-to-Tangible-Book

AstraZeneca Pharma India (BOM:506820) Price-to-Tangible-Book : 22.42 (As of May. 30, 2024)


View and export this data going back to 2001. Start your Free Trial

What is AstraZeneca Pharma India Price-to-Tangible-Book?

As of today (2024-05-30), AstraZeneca Pharma India's share price is ₹6366.00. AstraZeneca Pharma India's Tangible Book per Share of Mar. 2024 for the quarter that ended in Mar. 2024 was ₹283.92. Hence, AstraZeneca Pharma India's Price to Tangible Book Ratio of today is 22.42.

The historical rank and industry rank for AstraZeneca Pharma India's Price-to-Tangible-Book or its related term are showing as below:

BOM:506820' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 9.38   Med: 14.72   Max: 22.42
Current: 22.42

During the past 13 years, AstraZeneca Pharma India's highest Price to Tangible Book Ratio was 22.42. The lowest was 9.38. And the median was 14.72.

BOM:506820's Price-to-Tangible-Book is ranked worse than
95.93% of 860 companies
in the Drug Manufacturers industry
Industry Median: 2.33 vs BOM:506820: 22.42

A closely related ratio is called PB Ratio. As of today, AstraZeneca Pharma India's share price is ₹6366.00. AstraZeneca Pharma India's Book Value per Sharefor the quarter that ended in Mar. 2024 was ₹284.77. Hence, AstraZeneca Pharma India's P/B Ratio of today is 22.36.


AstraZeneca Pharma India Price-to-Tangible-Book Historical Data

The historical data trend for AstraZeneca Pharma India's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AstraZeneca Pharma India Price-to-Tangible-Book Chart

AstraZeneca Pharma India Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Price-to-Tangible-Book
Get a 7-Day Free Trial Premium Member Only Premium Member Only 16.41 16.50 12.49 13.79 18.74

AstraZeneca Pharma India Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Price-to-Tangible-Book Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 13.79 - 17.19 - 18.74

Competitive Comparison of AstraZeneca Pharma India's Price-to-Tangible-Book

For the Drug Manufacturers - Specialty & Generic subindustry, AstraZeneca Pharma India's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


AstraZeneca Pharma India's Price-to-Tangible-Book Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, AstraZeneca Pharma India's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where AstraZeneca Pharma India's Price-to-Tangible-Book falls into.



AstraZeneca Pharma India Price-to-Tangible-Book Calculation

AstraZeneca Pharma India's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book=Share Price/Tangible Book per Share (Q: Mar. 2024 )
=6366.00/283.923
=22.42

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.


AstraZeneca Pharma India Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of AstraZeneca Pharma India's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.


AstraZeneca Pharma India (BOM:506820) Business Description

Traded in Other Exchanges
Address
Outer Ring Road, Block N1, 12th Floor, Manyata Embassy Business Park, Rachenahalli, Bangalore, KA, IND, 560 045
AstraZeneca Pharma India Ltd is engaged in the manufacture, distribution, and marketing of pharmaceutical products. Its only operating segment being Healthcare. The company generates revenue from the sale of products such as Tablets, Injectables, and Inhalation. Geographically, it derives a majority of revenue from India. It focuses on areas such as Cardiovascular, Renal and Metabolism (CVRM), Oncology, Respiratory, Inflammation and Autoimmunity, Neuroscience and Infection and Vaccines.

AstraZeneca Pharma India (BOM:506820) Headlines

No Headlines